top of page

 

Pertuzumab-trastuzumab is a combination of two medicines used to treat a specific type of breast cancer called HER2-positive breast cancer. HER2-positive breast cancer means that the cancer cells have too much of a protein called HER2, which helps them grow and spread faster.

 

1. **Pertuzumab**: Pertuzumab is like a superhero medicine that fights against HER2-positive breast cancer. It works by blocking a protein called HER2 on the surface of cancer cells. This protein acts like a fuel for the cancer cells, helping them grow and spread. By blocking HER2, Pertuzumab slows down or even stops the growth of cancer cells, giving the body a chance to fight the cancer.

 

2. **Trastuzumab**: Trastuzumab is another superhero medicine that targets HER2-positive breast cancer. Like Pertuzumab, it works by blocking the HER2 protein on the surface of cancer cells. By doing this, Trastuzumab helps stop the cancer cells from growing and spreading, just like putting a stop sign in front of them.

 

Now, when these two medicines are combined, they form a powerful team against HER2-positive breast cancer. They work together to block the HER2 protein from different angles, making it harder for the cancer cells to grow and spread. This combination approach is often more effective than using just one medicine on its own.

 

Pertuzumab-trastuzumab is usually given as an infusion into a vein (intravenously) by a healthcare provider in a hospital or clinic. The dose and frequency of the infusions depend on factors like the type and stage of cancer being treated, as well as the patient's overall health.

 

Like any medicine, Pertuzumab-trastuzumab can cause side effects. Some common side effects include feeling tired, having diarrhea, or feeling sick to your stomach. Some people may also experience changes in their skin, like a rash or dryness. These side effects can vary from person to person, but doctors can help manage them to make treatment as comfortable as possible.

 

Overall, Pertuzumab-trastuzumab is a powerful combination of medicines that helps fight against HER2-positive breast cancer. By targeting the HER2 protein on cancer cells, these medicines give patients a better chance at beating their cancer and living a longer, healthier life.

 

Have any queries, book a consultation with our Oncology Clinical Specialist

Pertuzumab-trastuzumab

₹0.00Price
  • Pertuzumab-trastuzumab is like a superhero team-up against a certain kind of breast cancer called HER2-positive breast cancer.

    Now, HER2-positive breast cancer cells have too much of a protein called HER2, which helps them grow faster and spread. It's like they're on overdrive.

    Here's how Pertuzumab-trastuzumab works:

    1. **Pertuzumab**: Think of Pertuzumab as a blocker. It stops the HER2 protein from working properly on the surface of cancer cells. So, it's like putting a lock on the gas pedal of the cancer cells, slowing down their growth.

    2. **Trastuzumab**: Trastuzumab is another blocker, but it works in a slightly different way. It also targets the HER2 protein, but from a different angle. So, it's like putting another lock on the gas pedal, making it even harder for the cancer cells to grow.

    When you use Pertuzumab-trastuzumab together, it's like having two locks on the gas pedal of the cancer cells. This makes it really tough for them to grow and spread, giving the body a better chance to fight back against the cancer.

    So, in simple terms, Pertuzumab-trastuzumab is a powerful team of medicines that work together to slow down and stop the growth of HER2-positive breast cancer cells, helping patients to beat their cancer.

    Have any queries, book a consultation with our Oncology Clinical Specialist

bottom of page